-
EP3999072
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3999072
| EP3999072 - BORON-CONTAINING RHO KINASE INHIBITORS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 16.02.2024 Database last updated on 09.07.2024 | |
| Former | Request for examination was made Status updated on 22.04.2022 | ||
| Former | The international publication has been made Status updated on 22.01.2021 | Most recent event Tooltip | 17.06.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states Percipiad, Inc. 46 Steamwhistle Drive Warminster PA 18974 / US | [2022/21] | Inventor(s) | 01 /
HORMANN, Robert, Eugene 413 Richards Road Melrose Park, PA 19027 / US | 02 /
PADIDAM, Malla 228 Cassandra Drive Chalfont, PA 18914 / US | [2022/21] | Representative(s) | Studio Torta S.p.A., et al Via Viotti, 9 10121 Torino / IT | [N/P] |
| Former [2022/21] | Casciano, Lidia Giulia Rita, et al Studio Torta S.p.A. Via Viotti, 9 10121 Torino / IT | Application number, filing date | 20841243.7 | 17.07.2020 | [2022/21] | WO2020US42538 | Priority number, date | US201962875270P | 17.07.2019 Original published format: US 201962875270 P | [2022/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021011873 | Date: | 21.01.2021 | Language: | EN | [2021/03] | Type: | A1 Application with search report | No.: | EP3999072 | Date: | 25.05.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.01.2021 takes the place of the publication of the European patent application. | [2022/21] | Search report(s) | International search report - published on: | US | 21.01.2021 | (Supplementary) European search report - dispatched on: | EP | 07.06.2023 | Classification | IPC: | C07F5/02, A61P27/06, A61P25/28 | [2023/27] | CPC: |
C07F5/025 (EP,US);
A61K45/06 (US);
A61P25/28 (EP);
A61P27/06 (EP);
C07F5/02 (EP)
|
| Former IPC [2022/21] | A61K31/69, C07F5/02, A61P21/00, A61P25/28, A61P35/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/21] | Title | German: | BORHALTIGE RHO-KINASE-INHIBITOREN | [2022/21] | English: | BORON-CONTAINING RHO KINASE INHIBITORS | [2022/21] | French: | INHIBITEURS DE LA RHO KINASE CONTENANT DU BORE | [2022/21] | Entry into regional phase | 12.01.2022 | National basic fee paid | 12.01.2022 | Search fee paid | 12.01.2022 | Designation fee(s) paid | 12.01.2022 | Examination fee paid | Examination procedure | 12.01.2022 | Examination requested [2022/21] | 27.12.2023 | Amendment by applicant (claims and/or description) | 27.12.2023 | Date on which the examining division has become responsible | 15.02.2024 | Despatch of a communication from the examining division (Time limit: M04) | 14.06.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 18.07.2022 | Renewal fee patent year 03 | 24.07.2023 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A] - DAYAL NEETU ET AL, "Potently inhibiting cancer cell migration with novel 3H-pyrazolo[4,3-f]quinoline boronic acid ROCK inhibitors", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, ELSEVIER, AMSTERDAM, NL, vol. 180, doi:10.1016/J.EJMECH.2019.06.089, ISSN 0223-5234, (20190629), pages 449 - 456, (20190629), XP085819385 [A] 1-15 * figures 1-4 * * abstract * DOI: http://dx.doi.org/10.1016/j.ejmech.2019.06.089 | International search | [A]US2010280011 (DELONG MITCHELL A [US], et al) [A] 1, 15, 20/(1,15) * para [0165], [0167], [0191], Table 3 *; | [A]US2017137443 (WANG GUANGDI [US], et al) [A] 1, 15, 20/(1,15) * para [0017], [0021], Fig 9; Fig 10 *; | [A] - JIANG et al., "Boron-Based 4-Hydroxytamoxifen Bioisosteres for Treatment of de Novo Tamoxifen Resistant Breast Cancer", ACS Med. Chem. Lett., (20120000), vol. 3, doi:doi.org/10.1021/ml3000287., pages 392 - 396, XP055195676 [A] 1, 15, 20/(1,15) * abstract; pg 393, Fig 1; pg 394, coi 1, para 2 to pg 395, col 1, para 1 * DOI: http://dx.doi.org/10.1021/ml3000287 | [A] - Oliveira Ramon Guerra De, Guerra Fabiana Sélos, Mermelstein Cláudia Dos Santos, Fernandes Patrícia Dias, Bastos Isadora Tairinne De Sena, Costa Fanny Nascimento, Barroso Regina Cely Rodrigues, Ferreira Fabio Furlan, Fraga Carlos Alberto Manssour, "Synthesis and pharmacological evaluation of novel isoquinoline N-sulphonylhydrazones designed as ROCK inhibitors", JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, (20181200), vol. 33, no. 1, doi:https://doi.org/10.1080/14756366.2018.1490732., pages 1181 - 1193, XP055785427 [A] 1, 15, 20/(1,15) * pg 1182, col 1, para 2 to col 2, para 1; Fig 1; pg 1184, col 1, para 1 * DOI: http://dx.doi.org/10.1080/14756366.2018.1490732 |